• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断糖尿病和新发心肌梗死的短期和长期心血管风险变化——一项全国性研究。

Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction--a nationwide study.

机构信息

Department of Cardiology, Gentofte Hospital, Niels Andersens Vej 65, DK 2900 Hellerup, Denmark.

出版信息

Diabetologia. 2010 Aug;53(8):1612-9. doi: 10.1007/s00125-010-1783-z. Epub 2010 May 9.

DOI:10.1007/s00125-010-1783-z
PMID:20454950
Abstract

AIMS/HYPOTHESIS: We assessed secular trends of cardiovascular outcomes following first diagnosis of myocardial infarction (MI) or diabetes in an unselected population.

METHODS

All Danish residents aged > or = 30 years without prior diabetes or MI were identified by individual-level linkage of nationwide registers. Individuals hospitalised with MI or claiming a first-time prescription for a glucose-lowering medication (GLM) during the period from 1997 to 2006 were included. Analyses were by Poisson regression models. Primary endpoints were death by all causes, cardiovascular death and MI.

RESULTS

The study included 3,092,580 individuals, of whom 77,147 had incident MI and 118,247 new-onset diabetes. MI patients had an increased short-term risk of all endpoints compared with the general population. The rate ratio (RR) for cardiovascular death within the first year after MI was 11.1 (95% CI 10.8-11.5) in men and 14.8 (14.3-15.3) in women, respectively. The risk rapidly declined and 1 year after the index MI, RR was 2.11 (2.00-2.23) and 2.8 (2.64-2.97) in men and women, respectively. Patients with diabetes carried a constantly elevated risk of all endpoints compared with the general population. The cardiovascular death RR was 1.90 (1.77-2.04) and 1.92 (1.78-2.07) in men and women, respectively during the first year after GLM initiation.

CONCLUSIONS/INTERPRETATION: Incident MI is associated with high short-term risk, which decreases rapidly over time. Incident diabetes is associated with a persistent excessive cardiovascular risk after initiation of GLM therapy. This further strengthens the necessity of early multi-factorial intervention in diabetes patients for long-term benefit.

摘要

目的/假设:我们评估了在未经选择的人群中,首次诊断为心肌梗死(MI)或糖尿病后心血管结局的长期趋势。

方法

通过全国性登记册的个体水平链接,确定所有年龄≥30 岁且无既往糖尿病或 MI 的丹麦居民。在 1997 年至 2006 年期间,因 MI 住院或首次开具降血糖药物(GLM)处方的患者被纳入研究。分析采用泊松回归模型。主要终点是全因死亡、心血管死亡和 MI。

结果

本研究纳入了 3092580 名患者,其中 77147 例发生 MI,118247 例新诊断为糖尿病。与一般人群相比,MI 患者短期存在所有终点的风险增加。男性 MI 后 1 年内心血管死亡的比率比(RR)为 11.1(95%CI 10.8-11.5),女性为 14.8(14.3-15.3)。风险迅速下降,在 MI 后 1 年,RR 分别为男性 2.11(2.00-2.23)和女性 2.8(2.64-2.97)。与一般人群相比,糖尿病患者所有终点的风险持续升高。GLM 治疗开始后 1 年内,男性和女性的心血管死亡 RR 分别为 1.90(1.77-2.04)和 1.92(1.78-2.07)。

结论/解释:新发 MI 与短期高风险相关,且风险随时间迅速下降。新发糖尿病与 GLM 治疗开始后持续存在的过度心血管风险相关。这进一步强化了对糖尿病患者进行早期多因素干预以获得长期获益的必要性。

相似文献

1
Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction--a nationwide study.新诊断糖尿病和新发心肌梗死的短期和长期心血管风险变化——一项全国性研究。
Diabetologia. 2010 Aug;53(8):1612-9. doi: 10.1007/s00125-010-1783-z. Epub 2010 May 9.
2
Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006.首次心肌梗死后起始降血糖药物治疗的时间趋势 - 1997 年至 2006 年的全国性研究。
Cardiovasc Diabetol. 2011 Jan 19;10:5. doi: 10.1186/1475-2840-10-5.
3
Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.外周动脉疾病是男性和女性的冠心病等效风险:一项全国性研究的结果。
Eur J Prev Cardiol. 2015 Mar;22(3):317-25. doi: 10.1177/2047487313519344. Epub 2014 Jan 7.
4
Effects of oral glucose-lowering drugs on long term outcomes in patients with diabetes mellitus following myocardial infarction not treated with emergent percutaneous coronary intervention--a retrospective nationwide cohort study.口服降糖药物对未行急诊经皮冠状动脉介入治疗的心肌梗死后糖尿病患者长期结局的影响:一项回顾性全国性队列研究。
Cardiovasc Diabetol. 2010 Sep 16;9:54. doi: 10.1186/1475-2840-9-54.
5
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.与二甲双胍相比,不同胰岛素促分泌剂在有或无既往心肌梗死的 2 型糖尿病患者中的死亡率和心血管风险:一项全国性研究。
Eur Heart J. 2011 Aug;32(15):1900-8. doi: 10.1093/eurheartj/ehr077. Epub 2011 Apr 6.
6
Incidence of new onset cancer in patients with a myocardial infarction - a nationwide cohort study.心肌梗死患者新发癌症的发病率——一项全国性队列研究
BMC Cardiovasc Disord. 2018 Oct 22;18(1):198. doi: 10.1186/s12872-018-0932-z.
7
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.需要降糖治疗的糖尿病患者与既往有心肌梗死的非糖尿病患者具有相同的心血管风险:一项对330万人的人群研究。
Circulation. 2008 Apr 15;117(15):1945-54. doi: 10.1161/CIRCULATIONAHA.107.720847. Epub 2008 Mar 31.
8
Type of preadmission glucose-lowering treatment and prognosis among patients hospitalised with myocardial infarction: a nationwide follow-up study.心肌梗死住院患者入院前降糖治疗类型与预后:一项全国性随访研究
Diabetologia. 2008 Apr;51(4):567-74. doi: 10.1007/s00125-008-0947-6. Epub 2008 Feb 19.
9
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.达格列净与既往心肌梗死的 2 型糖尿病患者的心血管结局
Circulation. 2019 May 28;139(22):2516-2527. doi: 10.1161/CIRCULATIONAHA.119.039996. Epub 2019 Mar 18.
10
Long-Term Survival Among Patients With Myocardial Infarction Before Age 50 Compared With the General Population: A Danish Nationwide Cohort Study.50岁前心肌梗死患者与普通人群的长期生存率:一项丹麦全国队列研究。
Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):523-31. doi: 10.1161/CIRCOUTCOMES.115.002661. Epub 2016 Aug 30.

引用本文的文献

1
Time-Varying Effect of Physical Activity on Mortality Among Myocardial Infarction Survivors: A Nationwide Population-Based Cohort Study.身体活动对心肌梗死幸存者死亡率的时变效应:一项基于全国人群的队列研究
Rev Cardiovasc Med. 2023 Feb 22;24(3):67. doi: 10.31083/j.rcm2403067. eCollection 2023 Mar.
2
Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials.估算房颤人群中维生素 K 拮抗剂抗凝获益:来自 12 项随机试验的竞争风险证据。
Circ Cardiovasc Qual Outcomes. 2024 Apr;17(4):e010269. doi: 10.1161/CIRCOUTCOMES.123.010269. Epub 2024 Mar 25.
3

本文引用的文献

1
Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications 1997- 2006.1997年至2006年接受降糖药物治疗的糖尿病患者启动和持续他汀类药物治疗情况。
Open Cardiovasc Med J. 2009 Nov 12;3:152-9. doi: 10.2174/1874192400903010152.
2
Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005.1950年至2005年弗雷明汉心脏研究中患糖尿病和未患糖尿病的男性与女性的全因死亡率和心血管疾病死亡率趋势
Circulation. 2009 Apr 7;119(13):1728-35. doi: 10.1161/CIRCULATIONAHA.108.829176. Epub 2009 Mar 23.
3
Duration-dependent impact of cardiometabolic diseases and multimorbidity on all-cause and cause-specific mortality: a prospective cohort study of 0.5 million participants.
心血管代谢疾病和多种疾病与全因和病因特异性死亡率的时间依赖性关联:一项涉及 50 万名参与者的前瞻性队列研究。
Cardiovasc Diabetol. 2023 Jun 12;22(1):135. doi: 10.1186/s12933-023-01858-9.
4
Predictors of Readmission after the First Acute Coronary Syndrome and the Risk of Recurrent Cardiovascular Events-Seven Years of Patient Follow-Up.首次急性冠状动脉综合征后再入院的预测因素及复发性心血管事件的风险——七年患者随访
Life (Basel). 2023 Apr 4;13(4):950. doi: 10.3390/life13040950.
5
Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation.盐酸决奈达隆与胺碘酮治疗中国心房颤动患者的成本-效果分析。
Front Public Health. 2021 Aug 30;9:726294. doi: 10.3389/fpubh.2021.726294. eCollection 2021.
6
Health and productivity burden of coronary heart disease in the working Indonesian population using life-table modelling.利用寿命表模型评估工作印尼人群中心血管疾病的健康和生产力负担。
BMJ Open. 2020 Sep 9;10(9):e039221. doi: 10.1136/bmjopen-2020-039221.
7
Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage.德国2型糖尿病患者的真实世界胰岛素治疗:患者特征、治疗模式及胰岛素剂量
Diabetes Metab Syndr Obes. 2019 Jul 24;12:1225-1237. doi: 10.2147/DMSO.S214288. eCollection 2019.
8
Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review.急性心肌梗死幸存者第一年之后的死亡率和发病率趋势:一项系统评价
BMC Cardiovasc Disord. 2017 Feb 7;17(1):53. doi: 10.1186/s12872-017-0482-9.
9
[Platelet aggregation inhibitors and anticoagulants during ophthalmic interventions].[眼科干预期间的血小板聚集抑制剂和抗凝剂]
Ophthalmologe. 2016 Dec;113(12):1010-1022. doi: 10.1007/s00347-016-0368-8.
10
Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study.磺脲类药物治疗2型糖尿病患者的有效性:一项观察性队列研究。
J Diabetes Metab Disord. 2016 Aug 2;15:28. doi: 10.1186/s40200-016-0251-9. eCollection 2015.
Glucose control and vascular complications in veterans with type 2 diabetes.
2型糖尿病退伍军人的血糖控制与血管并发症
N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17.
4
10-year follow-up of intensive glucose control in type 2 diabetes.2型糖尿病强化血糖控制的10年随访
N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10.
5
Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study.糖尿病成年患者冠心病死亡率的长期下降:队列研究
BMJ. 2008 Jul 1;337(7661):a236. doi: 10.1136/bmj.39582.447998.BE.
6
Effects of intensive glucose lowering in type 2 diabetes.强化降糖对2型糖尿病的影响。
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
7
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.2型糖尿病患者强化血糖控制与血管转归
N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.
8
Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.出院后急性冠脉综合征患者二级预防药物治疗的应用
J Manag Care Pharm. 2008 Apr;14(3):271-80. doi: 10.18553/jmcp.2008.14.3.271.
9
Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.需要降糖治疗的糖尿病患者与既往有心肌梗死的非糖尿病患者具有相同的心血管风险:一项对330万人的人群研究。
Circulation. 2008 Apr 15;117(15):1945-54. doi: 10.1161/CIRCULATIONAHA.107.720847. Epub 2008 Mar 31.
10
Economic costs of diabetes in the U.S. In 2007.2007年美国糖尿病的经济成本。
Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017.